Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04483349 · ClinicalTrials.gov registry record
Assessment of What Patients and Healthcare Providers Value
A clinical trial of Pancreatic Adenocarcinoma and Gastric Adenocarcinoma, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 397
- Enrollment target
- 1
- Study location
NCT04483349: Completed study of Pancreatic Adenocarcinoma and Gastric Adenocarcinoma, sponsored by M.D. Anderson Cancer Center.
NCT04483349 is a study of Pancreatic Adenocarcinoma and Gastric Adenocarcinoma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 397 participants, below the 99,459-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04483349, a study of Pancreatic Adenocarcinoma and Gastric Adenocarcinoma, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 397 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurrence).
Primary Outcome
We will calculate the mean rank of patients yielding usable data and its corresponding 95% confidence interval. Patient characteristics and survey items will be summarized using descriptive statistics, including means, standard deviations (SDs), proportions, range, and 95% confidence intervals (CIs), etc.
Conditions Studied
Interventions
- OTHER Survey Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 397 participants |
| Start Date | 2020-06-11 |
| Est. Completion | 2022-08-11 |
What the finished NCT04483349 record still lists
NCT04483349 is an observational study that tracks outcomes without assigning an intervention. The registered 397 participants enrollment target is mid-sized for trials with a published cap, below the 99,459-participant average among 62 other Pancreatic Adenocarcinoma trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Pancreatic Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Survey Administration is the first listed.
NCT04483349 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04483349 about?
NCT04483349 is a clinical study titled "Assessment of What Patients and Healthcare Providers Value". To assess the importance patients place on each of the attributes of value (i.e., outcomes, quality of life \[QOL\], cost, experience), and how these patients’ views differ depending on the stage of their therapy (pretreatment, preoperative therapy, post-operative, long-term surveillance, recurren...
What is the current status of trial NCT04483349?
This trial is currently completed. The enrollment target is 397 participants. The study started on 2020-06-11. Estimated completion is 2022-08-11.
What conditions does trial NCT04483349 study?
This clinical trial studies the following conditions: Pancreatic Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Neuroendocrine Carcinoma.
What interventions are being tested in trial NCT04483349?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT04483349?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04483349 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04483349's enrollment target sits among peer trials
397 12th of 62 higher than 51 of 62 other Pancreatic Adenocarcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Adenocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RECRUITING · Phase 1
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RECRUITING · Phase 1
-
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RECRUITING · Phase 1
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
- NCT04115254 · 397 participants · NA
Stereotactic Magnetic Resonance Guided Radiation Therapy
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06227910 · 396 participants · Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI